Somatic activating mutations in the PIK3CA gene, encoding the p110α catalytic subunit of phosphatidylinositol 3-kinase (PI3K), were identified as causative of ~20% of venous malformations (VM)4–6, and the majority of lymphatic malformations (LM)7,8. This evidence concerns the gene PIK3CA and lymphatic malformation.